Drugs News and Research

RSS

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.

20 Oct 2009

FDA approves new oral medication for renal cell carcinoma

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005.

20 Oct 2009

Scientists find cause for lupuslike disease in mice

Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease.

19 Oct 2009

Federal grant for ecstasy research

A so-called "club drug" - typically not used all that often by those who take it - can still have the potential to cause a lot of damage among some users, say University of Cincinnati researchers. Trials are underway to trace the effects of ecstasy and to see who's most at risk. The study is supported by $471,000 in federal stimulus funds awarded by the National Institutes of Health and spread out over two years.

19 Oct 2009

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.

19 Oct 2009

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

Alcohol and drug use are known contributors to adolescents engaging in dangerous sexual activity; leading to substantial health risks such as unwanted pregnancies, sexually transmitted illnesses, drug overdoses and alcohol poisonings. Yet, research suggests that fewer than half of pediatricians report screening patients for substance use and at-risk sexual behavior.

19 Oct 2009

Viriom picks ChemDiv's Russian subsidiary for development of innovative HIV compounds

ChemDiv, Inc. of San Diego has proudly announced that its wholly owned subsidiary Chemical Diversity Research Institute (CDRI ) of Moscow, Russia, has been chosen by Viriom Ltd. ( Viriom) of Moscow, Russia as a service partner in developing innovative HIV compounds. The program includes pre-clinical and clinical studies, which are expected to begin in 2010.

19 Oct 2009

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.

19 Oct 2009

Majority of girls and young women well aware of HPV vaccine's benefits and limitations

Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections.

19 Oct 2009

Parents are concerned about the overuse of prescription medications with their children: Survey

A new nationwide survey released today reveals that just 12 percent of parents with children under the age of 18 have spoken to their child's doctor about complementary and integrative approaches to medicine, yet nearly 90 percent say they want to know more.

19 Oct 2009

Angiochem announces results of Phase 1 /2 clinical trials of ANG1005

19 Oct 2009

New chromosomal abnormality in acute lymphoblastic leukemia

Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.

19 Oct 2009

Antibiotic resistance to be undesirable consequence of antibiotic abuse is inaccurate, reveals report

The perception that antibiotic resistance is primarily the undesirable consequence of antibiotic abuse or misuse is a view that is simplistic and inaccurate, according to a recent report by the American Academy of Microbiology. The reasons behind the spread of resistance are much more complex, including appropriate antibiotic use, lack of proper sanitation and hygiene, and even the environment.

19 Oct 2009

Novel HIV drug to be studied in cell cultures and patients

A $6 million, five-year federal grant to The Children's Hospital of Philadelphia Research Institute will enable researchers to investigate a novel approach in treating HIV infection---a unique class of drugs focused on developing therapies for psychological and neurological effects in AIDS.

19 Oct 2009

Cultural frameworks and institutional practices for quality health care

As health care moves to the forefront of the national discourse, new research in the social sciences argues that the health of the population and the success or failure of many public health initiatives hinges as much on cultural and social factors as it does on doctors, facilities, or drugs.

19 Oct 2009

PHARMACIA & UPJOHN COMPANY to pay the largest criminal fine ever imposed in the U.S.

PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.

19 Oct 2009

Ruthenium and Osmium compounds show high levels of activity against ovarian cancer

Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds.

19 Oct 2009

Also in global health news: Street pharmacies; China health care; Hospital safety; African cardinals; Cells phones for health

Agence France-Presse examines Adjegounle, the "drugs" district in Benin. Although some are able to support their families by selling drugs at "street pharmacies," a minimum of "250 deaths and 340 cases of chronic illnesses linked to such drugs were recorded between April 2007 and June 2008," according to a medical thesis, the news service writes.

19 Oct 2009

FDA urges consumers to exercise care on online H1N1 drug products

The U.S. Food and Drug Administration today warned consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus.

19 Oct 2009

Rituxan drug effective for treating ANCA-associated vasculitis

Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy.

19 Oct 2009

Drugs News and Research

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

FDA approves new oral medication for renal cell carcinoma

Scientists find cause for lupuslike disease in mice

Federal grant for ecstasy research

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

Viriom picks ChemDiv's Russian subsidiary for development of innovative HIV compounds

Angiochem reports Phase 1/2 efficacy study results of ANG1005 for treating brain cancer

Majority of girls and young women well aware of HPV vaccine's benefits and limitations

Parents are concerned about the overuse of prescription medications with their children: Survey

Angiochem announces results of Phase 1 /2 clinical trials of ANG1005

New chromosomal abnormality in acute lymphoblastic leukemia

Antibiotic resistance to be undesirable consequence of antibiotic abuse is inaccurate, reveals report

Novel HIV drug to be studied in cell cultures and patients

Cultural frameworks and institutional practices for quality health care

PHARMACIA & UPJOHN COMPANY to pay the largest criminal fine ever imposed in the U.S.

Ruthenium and Osmium compounds show high levels of activity against ovarian cancer

Also in global health news: Street pharmacies; China health care; Hospital safety; African cardinals; Cells phones for health

FDA urges consumers to exercise care on online H1N1 drug products

Rituxan drug effective for treating ANCA-associated vasculitis

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News